139 related articles for article (PubMed ID: 23608738)
21. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma.
Marrero JA; Romano PR; Nikolaeva O; Steel L; Mehta A; Fimmel CJ; Comunale MA; D'Amelio A; Lok AS; Block TM
J Hepatol; 2005 Dec; 43(6):1007-12. PubMed ID: 16137783
[TBL] [Abstract][Full Text] [Related]
22. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882
[TBL] [Abstract][Full Text] [Related]
23. Serum 90K/MAC-2BP glycoprotein levels in hepatocellular carcinoma and cirrhosis.
Correale M; Giannuzzi V; Iacovazzi PA; Valenza MA; Lanzillotta S; Abbate I; Quaranta M; Caruso ML; Elba S; Manghisi OG
Anticancer Res; 1999; 19(4C):3469-72. PubMed ID: 10629637
[TBL] [Abstract][Full Text] [Related]
24. Manganese superoxide dismutase activity and incidence of hepatocellular carcinoma in patients with Child-Pugh class A liver cirrhosis: a 7-year follow-up study.
Clemente C; Elba S; Buongiorno G; Guerra V; D'Attoma B; Orlando A; Russo F
Liver Int; 2007 Aug; 27(6):791-7. PubMed ID: 17617122
[TBL] [Abstract][Full Text] [Related]
25. Value of serum protective activity against acid precipitation of poly (U) in the differentiation between cirrhotic patients with and without hepatocellular carcinoma.
Kouretas D; Kountouras J; Tsapas G; Anastasiades N; Tsakiri I; Antonoglou O
Anticancer Res; 1990; 10(4):1025-8. PubMed ID: 1696444
[TBL] [Abstract][Full Text] [Related]
26. The serum tissue polypeptide antigen in the detection of hepatocellular carcinoma in cirrhotic patients.
Leandro G; Zizzari S; Piccoli A; Manghisi OG
Hepatogastroenterology; 1990 Oct; 37(5):449-51. PubMed ID: 2174822
[TBL] [Abstract][Full Text] [Related]
27. A combination of α-fetoprotein and des-γ-carboxy prothrombin is superior in detection of hepatocellular carcinoma.
Ertle JM; Heider D; Wichert M; Keller B; Kueper R; Hilgard P; Gerken G; Schlaak JF
Digestion; 2013; 87(2):121-31. PubMed ID: 23406785
[TBL] [Abstract][Full Text] [Related]
28. Angiopoietin-2 serum levels are elevated in patients with liver cirrhosis and hepatocellular carcinoma.
Scholz A; Rehm VA; Rieke S; Derkow K; Schulz P; Neumann K; Koch I; Pascu M; Wiedenmann B; Berg T; Schott E
Am J Gastroenterol; 2007 Nov; 102(11):2471-81. PubMed ID: 17581268
[TBL] [Abstract][Full Text] [Related]
29. Discovery of lamin B1 and vimentin as circulating biomarkers for early hepatocellular carcinoma.
Wong KF; Luk JM
Methods Mol Biol; 2012; 909():295-310. PubMed ID: 22903723
[TBL] [Abstract][Full Text] [Related]
30. Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in Thailand.
Tangkijvanich P; Tosukhowong P; Bunyongyod P; Lertmaharit S; Hanvivatvong O; Kullavanijaya P; Poovorawan Y
Southeast Asian J Trop Med Public Health; 1999 Mar; 30(1):110-4. PubMed ID: 10695798
[TBL] [Abstract][Full Text] [Related]
31. Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease.
Ando E; Kuromatsu R; Tanaka M; Takada A; Fukushima N; Sumie S; Nagaoka S; Akiyoshi J; Inoue K; Torimura T; Kumashiro R; Ueno T; Sata M
J Clin Gastroenterol; 2006; 40(10):942-8. PubMed ID: 17063116
[TBL] [Abstract][Full Text] [Related]
32. Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma.
Cui R; Wang B; Ding H; Shen H; Li Y; Chen X
Chin Med J (Engl); 2002 Jan; 115(1):42-5. PubMed ID: 11930656
[TBL] [Abstract][Full Text] [Related]
33. [Detection of alpha-fetoprotein-L3 using agglutinin-coupled spin column to be used in diagnosis of hepatocellular carcinoma].
Sun GZ; Zhao XY; Li JH; Zhao GQ; Wang SX; Kong SL
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1986-8. PubMed ID: 19062741
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic value of the copper/zinc ratio in hepatocellular carcinoma: a case control study.
Poo JL; Rosas-Romero R; Montemayor AC; Isoard F; Uribe M
J Gastroenterol; 2003; 38(1):45-51. PubMed ID: 12560921
[TBL] [Abstract][Full Text] [Related]
35. Metabonomic profiles discriminate hepatocellular carcinoma from liver cirrhosis by ultraperformance liquid chromatography-mass spectrometry.
Wang B; Chen D; Chen Y; Hu Z; Cao M; Xie Q; Chen Y; Xu J; Zheng S; Li L
J Proteome Res; 2012 Feb; 11(2):1217-27. PubMed ID: 22200553
[TBL] [Abstract][Full Text] [Related]
36. Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<= 2.0 cm) in patients with hepatitis-induced liver cirrhosis.
Park MJ; Kim YK; Lee MH; Lee JH
Acta Radiol; 2013 Mar; 54(2):127-36. PubMed ID: 23148300
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of circulating activin-A as a serum marker of hepatocellular carcinoma.
Pirisi M; Fabris C; Luisi S; Santuz M; Toniutto P; Vitulli D; Federico E; Del Forno M; Mattiuzzo M; Branca B; Petraglia F
Cancer Detect Prev; 2000; 24(2):150-5. PubMed ID: 10917135
[TBL] [Abstract][Full Text] [Related]
38. Identifying serological biomarkers of hepatocellular carcinoma using surface-enhanced laser desorption/ionization-time-of-flight mass spectroscopy.
Wu FX; Wang Q; Zhang ZM; Huang S; Yuan WP; Liu JY; Ban KC; Zhao YN
Cancer Lett; 2009 Jul; 279(2):163-70. PubMed ID: 19268439
[TBL] [Abstract][Full Text] [Related]
39. Clinical application of determining serum AFP-IgM complexes for diagnosis of small hepatocellular carcinoma.
Jiang J; Wu C; Shen Y; Xu B; Zheng X; Li X; Xu N
Anticancer Res; 2011 Feb; 31(2):687-91. PubMed ID: 21378357
[TBL] [Abstract][Full Text] [Related]
40. A serum metabolomic investigation on hepatocellular carcinoma patients by chemical derivatization followed by gas chromatography/mass spectrometry.
Xue R; Lin Z; Deng C; Dong L; Liu T; Wang J; Shen X
Rapid Commun Mass Spectrom; 2008 Oct; 22(19):3061-8. PubMed ID: 18767022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
